Novo Nordisk A/S (NYSE:NVO) & Pasithea Therapeutics (NASDAQ:KTTA) Head-To-Head Analysis
Novo Nordisk A/S (NYSE:NVO – Get Free Report) and Pasithea Therapeutics (NASDAQ:KTTA – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership. Institutional and Insider Ownership 11.5% of Novo […]
More Stories
Israel: New law blocking UNRWA ‘would be a catastrophe’, Guterres warns
Two bills before the Israeli parliament could put a halt to the lifesaving operations of UN Palestine relief agency, UNRWA,...
Brokerages Set LENZ Therapeutics, Inc. (NASDAQ:LENZ) Price Target at $35.40
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) has been assigned an average recommendation of “Buy” from the seven research...
Analysts Set Spirax-Sarco Engineering plc (LON:SPX) Price Target at GBX 9,158
Spirax-Sarco Engineering plc (LON:SPX – Get Free Report) has been given an average rating of “Reduce” by the eight ratings...
Markel Group Inc. (NYSE:MKL) Receives $1,626.83 Average Target Price from Analysts
Markel Group Inc. (NYSE:MKL – Get Free Report) has been assigned an average recommendation of “Hold” from the six brokerages...
UWM Holdings Co. (NYSE:UWMC) Given Consensus Rating of “Reduce” by Analysts
UWM Holdings Co. (NYSE:UWMC – Get Free Report) has been given a consensus recommendation of “Reduce” by the seven research...
Endava plc (NYSE:DAVA) Given Average Rating of “Moderate Buy” by Brokerages
Endava plc (NYSE:DAVA – Get Free Report) has received an average rating of “Moderate Buy” from the ten ratings firms...